Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells

Liang Zhang, Huanyu Wang, Tianshu Yang, Zhifeng Su, Dan Fang, Yafeng Wang, Jiazhu Fang, Xinwei Hou, Yingying Le, Keqiang Chen, Ji Ming Wang, Shao Bo Su, Qing Lin, Qi Zhou

Research output: Contribution to journalArticle

Abstract

G protein-coupled chemoattractant receptors (GPCRs) have been implicated in cancer progression. Formylpeptide receptor 1 (FPR1) was originally identified as a GPCR mediating anti-microbial host defense. However, the role of FPR1 in tumorigenesis remains poorly understood. The current study aims to investigate the potential of FPR1 to regulate human hepatoma growth and invasion. We found the FPR1 gene and protein expression in human intratumoral and peritumoral tissues of hepatocellular carcinoma (HCC) specimens and in human hepatoma cell lines. FPR1 activation mediated the migration, calcium mobilization and ERK-dependent IL-8 production by hepatic cancer cells. FPR1 knockdown substantially reduced the tumorigenicity of hepatoma cells in nude mice. Necrotic hepatic tumor cells released factor(s) that activated FPR1 in live tumor cells. Our results indicate a critical role of FPR1 in the progression of malignant human hepatic cancer. FPR1 thus may represent a molecular target for the development of novel anti-hepatoma therapeutics.

Original languageEnglish (US)
JournalOncoImmunology
Volume5
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Hepatocellular Carcinoma
Formyl Peptide Receptor
Liver Neoplasms
G-Protein-Coupled Receptors
Hepatocytes
Neoplasms
Interleukin-8
Nude Mice
Carcinogenesis
Calcium
Gene Expression
Cell Line
Growth
Proteins
Therapeutics

Keywords

  • Cancer
  • GPCR
  • HepG2
  • IL-8
  • liver

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells. / Zhang, Liang; Wang, Huanyu; Yang, Tianshu; Su, Zhifeng; Fang, Dan; Wang, Yafeng; Fang, Jiazhu; Hou, Xinwei; Le, Yingying; Chen, Keqiang; Wang, Ji Ming; Su, Shao Bo; Lin, Qing; Zhou, Qi.

In: OncoImmunology, Vol. 5, No. 2, 01.02.2016.

Research output: Contribution to journalArticle

Zhang, L, Wang, H, Yang, T, Su, Z, Fang, D, Wang, Y, Fang, J, Hou, X, Le, Y, Chen, K, Wang, JM, Su, SB, Lin, Q & Zhou, Q 2016, 'Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells', OncoImmunology, vol. 5, no. 2. https://doi.org/10.1080/2162402X.2015.1078055
Zhang, Liang ; Wang, Huanyu ; Yang, Tianshu ; Su, Zhifeng ; Fang, Dan ; Wang, Yafeng ; Fang, Jiazhu ; Hou, Xinwei ; Le, Yingying ; Chen, Keqiang ; Wang, Ji Ming ; Su, Shao Bo ; Lin, Qing ; Zhou, Qi. / Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells. In: OncoImmunology. 2016 ; Vol. 5, No. 2.
@article{ceee43abaf95455e975728b9838bea71,
title = "Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells",
abstract = "G protein-coupled chemoattractant receptors (GPCRs) have been implicated in cancer progression. Formylpeptide receptor 1 (FPR1) was originally identified as a GPCR mediating anti-microbial host defense. However, the role of FPR1 in tumorigenesis remains poorly understood. The current study aims to investigate the potential of FPR1 to regulate human hepatoma growth and invasion. We found the FPR1 gene and protein expression in human intratumoral and peritumoral tissues of hepatocellular carcinoma (HCC) specimens and in human hepatoma cell lines. FPR1 activation mediated the migration, calcium mobilization and ERK-dependent IL-8 production by hepatic cancer cells. FPR1 knockdown substantially reduced the tumorigenicity of hepatoma cells in nude mice. Necrotic hepatic tumor cells released factor(s) that activated FPR1 in live tumor cells. Our results indicate a critical role of FPR1 in the progression of malignant human hepatic cancer. FPR1 thus may represent a molecular target for the development of novel anti-hepatoma therapeutics.",
keywords = "Cancer, GPCR, HepG2, IL-8, liver",
author = "Liang Zhang and Huanyu Wang and Tianshu Yang and Zhifeng Su and Dan Fang and Yafeng Wang and Jiazhu Fang and Xinwei Hou and Yingying Le and Keqiang Chen and Wang, {Ji Ming} and Su, {Shao Bo} and Qing Lin and Qi Zhou",
year = "2016",
month = "2",
day = "1",
doi = "10.1080/2162402X.2015.1078055",
language = "English (US)",
volume = "5",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Landes Bioscience",
number = "2",

}

TY - JOUR

T1 - Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells

AU - Zhang, Liang

AU - Wang, Huanyu

AU - Yang, Tianshu

AU - Su, Zhifeng

AU - Fang, Dan

AU - Wang, Yafeng

AU - Fang, Jiazhu

AU - Hou, Xinwei

AU - Le, Yingying

AU - Chen, Keqiang

AU - Wang, Ji Ming

AU - Su, Shao Bo

AU - Lin, Qing

AU - Zhou, Qi

PY - 2016/2/1

Y1 - 2016/2/1

N2 - G protein-coupled chemoattractant receptors (GPCRs) have been implicated in cancer progression. Formylpeptide receptor 1 (FPR1) was originally identified as a GPCR mediating anti-microbial host defense. However, the role of FPR1 in tumorigenesis remains poorly understood. The current study aims to investigate the potential of FPR1 to regulate human hepatoma growth and invasion. We found the FPR1 gene and protein expression in human intratumoral and peritumoral tissues of hepatocellular carcinoma (HCC) specimens and in human hepatoma cell lines. FPR1 activation mediated the migration, calcium mobilization and ERK-dependent IL-8 production by hepatic cancer cells. FPR1 knockdown substantially reduced the tumorigenicity of hepatoma cells in nude mice. Necrotic hepatic tumor cells released factor(s) that activated FPR1 in live tumor cells. Our results indicate a critical role of FPR1 in the progression of malignant human hepatic cancer. FPR1 thus may represent a molecular target for the development of novel anti-hepatoma therapeutics.

AB - G protein-coupled chemoattractant receptors (GPCRs) have been implicated in cancer progression. Formylpeptide receptor 1 (FPR1) was originally identified as a GPCR mediating anti-microbial host defense. However, the role of FPR1 in tumorigenesis remains poorly understood. The current study aims to investigate the potential of FPR1 to regulate human hepatoma growth and invasion. We found the FPR1 gene and protein expression in human intratumoral and peritumoral tissues of hepatocellular carcinoma (HCC) specimens and in human hepatoma cell lines. FPR1 activation mediated the migration, calcium mobilization and ERK-dependent IL-8 production by hepatic cancer cells. FPR1 knockdown substantially reduced the tumorigenicity of hepatoma cells in nude mice. Necrotic hepatic tumor cells released factor(s) that activated FPR1 in live tumor cells. Our results indicate a critical role of FPR1 in the progression of malignant human hepatic cancer. FPR1 thus may represent a molecular target for the development of novel anti-hepatoma therapeutics.

KW - Cancer

KW - GPCR

KW - HepG2

KW - IL-8

KW - liver

UR - http://www.scopus.com/inward/record.url?scp=84959420051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959420051&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2015.1078055

DO - 10.1080/2162402X.2015.1078055

M3 - Article

VL - 5

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 2

ER -